Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Viltolarsen

The articles shown below are all about the Viltolarsen, through these related articles, you can get relevant information, notes in use, or latest trends about the Viltolarsen. We hope these news will give you the help you need. And if these Viltolarsen articles can't solve your needs, you can contact us for relevant information.
  • Drug Patent & Exclusivity Expiration Report - Week of Aug 11 2025

    Drug Patent & Exclusivity Expiration Report - Week of Aug 11 2025

    2025-08-11

    This week, there are 6 drugs in the patent and exclusivity list. They are: - NOVO NORDISK INC's OZEMPIC, containing active ingredient SEMAGLUTIDE - NOVO NORDISK INC's VICTOZA, containing active ingredient LIRAGLUTIDE - NOVO NORDISK INC's SAXENDA, containing active ingredient LIRAGLUTIDE - NIPPON SHINYAKU CO LTD's VILTEPSO, containing active ingredient VILTOLARSEN - VERTEX PHARMACEUTICALS INC's KALYDECO, containing active ingredient IVACAFTOR - EISAI INC's LENVIMA, containing active ingredient LENVATINIB MESYLATE Read More